These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 667865)

  • 1. Subclinical adriamycin cardiotoxicity: detection by timing the arterial sounds.
    Greco FA
    Cancer Treat Rep; 1978 Jun; 62(6):901-5. PubMed ID: 667865
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of adriamycin cardiotoxicity by echocardiography.
    Ewy GA; Jones SE; Groves BM; Gaines JA
    Ariz Med; 1978 Jun; 35(6):402-5. PubMed ID: 687134
    [No Abstract]   [Full Text] [Related]  

  • 3. Systolic time intervals in monitoring adriamycin-induced cardiotoxicity.
    Balcerzak SP; Christakis J; Lewis RP; Olson HM; Malspeis L
    Cancer Treat Rep; 1978 Jun; 62(6):893-9. PubMed ID: 667864
    [No Abstract]   [Full Text] [Related]  

  • 4. Noninvasive profile in the prospective monitoring of adriamycin cardiomyopathy.
    Fulkerson PK; Talley R; Kleinman D; Weaver SK; Leier CV; Balcerzak SP; Lewis RP
    Cancer Treat Rep; 1978 Jun; 62(6):881-6. PubMed ID: 667862
    [No Abstract]   [Full Text] [Related]  

  • 5. Noninvasive cardiac evaluation of patients receiving adriamycin.
    Ewy GA; Jones SE; Friedman MJ; Gaines J; Cruze D
    Cancer Treat Rep; 1978 Jun; 62(6):915-22. PubMed ID: 667868
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiotoxicity of adriamycin].
    Mordeglia F; Mirassou C
    Medicina (B Aires); 1979; 39(3):423-5. PubMed ID: 514062
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy].
    Svojgrová M; Slechtová J; Hůla J
    Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
    Greco FA; Brereton HD; Rodbard D
    Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Echocardiographic evaluation of adriamycin cardiotoxicity during polychemotherapy (author's transl)].
    Christmann D; Bareiss P; Boilletot A; Bergerat JP; Oberling F
    Nouv Rev Fr Hematol (1978); 1981; 23(3):149-54. PubMed ID: 7290990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients.
    Hutchinson RJ; Bailey C; Wood D; Donaldson MH
    Cancer Treat Rep; 1978 Jun; 62(6):907-10. PubMed ID: 667866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats.
    Mettler FP; Young DM; Ward JM
    Cancer Res; 1977 Aug; 37(8 Pt 1):2705-13. PubMed ID: 872096
    [No Abstract]   [Full Text] [Related]  

  • 12. Systolic time intervals: an effective measure of cardiac function in anthracycline-induced cardiomyopathy of rabbits.
    Long HJ
    Cancer Treat Rep; 1978 Jun; 62(6):911-4. PubMed ID: 667867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adriamycin: cardiotoxicity].
    Gamna G; Lovisetto P; Pochnettino G; Biarese V
    Boll Soc Ital Cardiol; 1974; 19(7):633-70. PubMed ID: 4464961
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac toxicity of adriamycin-DNA complex and rubidazone: evaluation by electrocardiogram and endomyocardial biopsy.
    Benjamin RS; Mason JW; Billingham ME
    Cancer Treat Rep; 1978 Jun; 62(6):935-9. PubMed ID: 667871
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adriamycin cardiotoxicity].
    Recalcatri F; Villa A; Belli C
    G Ital Cardiol; 1982; 12(8):612-6. PubMed ID: 7169160
    [No Abstract]   [Full Text] [Related]  

  • 16. Doxorubicin cardiotoxicity in the elderly: old drugs and new opportunities.
    Carver JR; Schuster SJ; Glick JH
    J Clin Oncol; 2008 Jul; 26(19):3122-4. PubMed ID: 18591552
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polycardiographic evaluation of the cardiotoxicity of adriamycin].
    Villani F; Beretta G; Guindani A; Pagnoni A; Vivarelli S
    G Ital Chemioter; 1975; 22(1-2):39-46. PubMed ID: 1235351
    [No Abstract]   [Full Text] [Related]  

  • 18. [Non-invasive methods in the monitoring of patients treated with adriamycin].
    Rozo L; Carlier R; Fumoleau P; Nicolas G
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1341-8. PubMed ID: 6797373
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicin.
    Villani F; Galimberti M; Comazzi R; Crippa F; Bonfante V; Ferrari L; Pacciarini MA
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):185-9. PubMed ID: 3403095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effect of coenzyme Q10 in cardiotoxicity induced by adriamycin].
    Okuma K; Furuta I; Ota K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):502-8. PubMed ID: 6703724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.